Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer

被引:0
作者
Haojun Shi
Yiusing Tsang
Yisi Yang
机构
[1] Ruijin Hospital,Department of General Surgery
[2] Shanghai Jiao Tong University School of Medicine,Graduate School of Asia
[3] Shanghai Institute for Endocrine and Metabolic Diseases,Pacific Studies
[4] Ruijin Hospital,undefined
[5] Shanghai Jiao Tong University School of Medicine,undefined
[6] Waseda University,undefined
来源
BMC Cancer | / 22卷
关键词
Pancreatic cancer; Cancer stemness; CEACAM5; Immune checkpoint; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 421 条
[21]  
Royal RE(2010)A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma PLoS Med 7 338-354 e315
[22]  
Levy C(2018)Machine learning identifies stemness features associated with oncogenic dedifferentiation Cell 173 1550-1558
[23]  
Turner K(2018)Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response Nat Med 24 218-457
[24]  
Mathur A(2016)Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression Genome Biol 17 453-412
[25]  
Hughes M(2015)Robust enumeration of cell subsets from tissue expression profiles Nat Methods 12 411-700
[26]  
Kammula US(2019)The immune landscape of cancer Immunity 51 689-859
[27]  
Sherry RM(2020)Overcoming Wnt-beta-catenin dependent anticancer therapy resistance in leukaemia stem cells Nat Cell Biol 22 842-5068
[28]  
Topalian SL(2021)Tumor-infiltrating lymphocytes in the immunotherapy era Cell Mol Immunol 18 5056-586 e522
[29]  
Yang JC(2021)Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer Bioengineered 12 572-140
[30]  
Lowy I(2019)A multiscale map of the stem cell state in pancreatic adenocarcinoma Cell 177 127-232